Why Did Ketamine One Choose To Acquire KGK, And How doe this Acquisition Add To Your Overall Strategy?

Adam Deffett, Interim CEO at Ketamine One discusses the acquisition of KGK, Clinical Trials and the benefit to doctors and patients..